Generation of three-dimensional meat-like tissue from stable pig epiblast stem cells
You guys are probably sick of hearing about the challenges of CBM 😂 but here we are. Cultivated meat innovation is a long, drawn-out process unlikely to change the world with a bang. Innovation takes time, even with advancements in AI and Quantum technology. Occasionally, however, there are breakthroughs in food technology. This time, a team of researchers from Beijing, China, tackled the challenge of sustainable meat production by developing cultured meat using porcine pre-gastrulation epiblast stem cells (pgEpiSCs). If you read that as prgaebpiglablacells, that’s fine; stay with me.
PgEpiSCs [feel free to call them pig cells] are derived from the early developmental stage of pig embryos, specifically from the epiblast layer. These pluripotent cells can develop into almost any cell type in the pig’s body. In cultured meat production, pgEpiSCs are vital as they can be converted into muscle cells, offering a sustainable alternative to conventional meat production. pgEpiSCs offer an advantage over other stem cells due to their ability to be cultured for extended periods without losing their differentiation potential, making them suitable for large-scale cultured meat production.
I can honestly advise anyone with an interest in #cultivatedmeat to read this study because it is so interesting and comprehensive! The study addresses the challenge of finding stable cell lines with the capacity for long-term expansion for CM production. As mentioned, past efforts used various muscle stem cells (MuSCs), which have limitations in long-term in vitro expansion. They address developing a culture medium without serum (a component often derived from animals). It covers scaffold construction, which supports cell growth and is entirely free of animal products. The paper discusses the successful use of pgEpiSCs, which can be stably passaged in vitro, maintaining their genomic stability without significant DNA damage or cancerous characteristics in great detail.
To confirm the accuracy of the differentiation process, the research also includes an in-depth analysis of both the transcriptomic (gene expression) and metabolic levels. The team discusses future challenges in cultured-meat production with pgEpiSCs, which involve simplifying the complex differentiation process for better industrial scalability and reducing high production costs through biosynthesis and standardising inputs like serum substitutes and growth factors. The study also emphasises strict adherence to ethical standards in animal treatment and provides detailed methodologies for cell culture and scaffold preparation, aligning with institutional guidelines.